As I’ve blogged before, the usefulness of the whole-genome scans offered by personal genomics companies is very much subject to debate. It’s not clear just what one is supposed to be able to do with the test results, beyond being fascinated and entertained. But at very least, consumers are bound to expect the tests to be scientifically credible.

Well, the biggest name in genomics has just hurled a bit of a challenge in the direction of 2 personal genomics companies, in that regard.

Four scientists – including the omnipresent J. Craig Venter (left) – have penned an opinion piece in the latest issue of Nature based results from five individuals genotyped by two separate personal genomics companies. The article highlights some deficiencies in the way that genetic data are currently used by direct-to-consumer companies to generate risk predictions and to present them to customers.

Biotech Ethics BLOG

This blog is about ethical issues in the biotechnology industry. That includes all 3 main areas of that industry: health biotech, food biotech, and industrial biotech. (The last two are particularly important, and don't get enough attention.)

Unlike my Business Ethics Blog, this one will focus on aggregating information, rather than offering much commentary.